Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleNEUROPHARMACOLOGY

Desensitization of 5-HT1A Receptors by 5-HT2A Receptors in Neuroendocrine Neurons in Vivo

Yahong Zhang, Thackery S. Gray, Deborah N. D'Souza, Gonzalo A. Carrasco, Katerina J. Damjanoska, Bertalan Dudas, Francisca Garcia, Gina M. Zainelli, Nicole R. Sullivan Hanley, George Battaglia, Nancy A. Muma and Louis D. Van de Kar
Journal of Pharmacology and Experimental Therapeutics July 2004, 310 (1) 59-66; DOI: https://doi.org/10.1124/jpet.103.062224
Yahong Zhang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thackery S. Gray
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deborah N. D'Souza
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gonzalo A. Carrasco
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katerina J. Damjanoska
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bertalan Dudas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francisca Garcia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gina M. Zainelli
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicole R. Sullivan Hanley
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George Battaglia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nancy A. Muma
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Louis D. Van de Kar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

An imbalance between serotonin-2A (5-HT2A) and 5-HT1A receptors may underlie several mood disorders. The present studies determined whether 5-HT2A receptors interact with 5-HT1A receptors in the rat hypothalamic paraventricular nucleus (PVN). The sensitivity of the hypothalamic 5-HT1A receptors was measured as oxytocin and adrenocorticotropic hormone (ACTH) responses to the 5-HT1A receptor agonist (+)-8-hydroxy-2-(di-n-propylamino) tetralin hydrobromide [(+)8-OH-DPAT] (40 μg/kg s.c.). The 5-HT2A/2C receptor agonist (-)DOI [(-)-1-(2,5-dimethoxy-4-iodophenyl)2-aminopropane HCl] (1 mg/kg s.c.) injected 2 h prior to (+)8-OH-DPAT significantly reduced the oxytocin and ACTH responses to (+)8-OH-DPAT, producing a heterologous desensitization of the 5-HT1A receptors. Microinjection of the 5-HT2A receptor antagonist MDL100,907 [(+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenylethyl)]-4-piperidinemethanol; 0, 10, or 20 nmol, 15 min prior to (-)DOI] into the PVN dose-dependently prevented the desensitization of 5-HT1A receptors induced by the 5-HT2A receptor agonist (-)DOI. Double-label immunocytochemistry revealed a high degree of colocalization of 5-HT1A and 5-HT2A receptors in the oxytocin and corticotropin-releasing factor neurons of the PVN. Thus, activation of 5-HT2A receptors in the PVN may directly induce a heterologous desensitization of 5-HT1A receptors within individual neuroendocrine cells. These findings may provide insight into the long-term adaptation of 5-HT1A receptor signaling after changes in function of 5-HT2A receptors; for example, during pharmacotherapy of mood disorders.

Footnotes

  • This study was supported in part by U.S. Public Health Service Grants RO1 NS 34153, RO1 MH 58448, and RO1 DA13669 (to L.D.V.d.K.), RO1 NS38059 (to N.A.M.), and RO1 MH60687 (to G.B.)

  • DOI: 10.1124/jpet.103.062224.

  • ABBREVIATIONS: 5-HT, 5-hydroxytryptamine; PVN, paraventricular nucleus; ACTH, adrenocorticotropic hormone; (+)8-OH-DPAT, (+)-8-hydroxy-2-(di-n-propylamino) tetralin hydrobromide; CRF, corticotropin-releasing factor; MDL100,907, (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenylethyl)]-4-piperidinemethanol; (-)DOI, (-)-1-(2,5-dimethoxy-4-iodophenyl)2-aminopropane HCl; PBS, phosphate-buffered saline; DAB, 3,3′-diaminobenzidine tetrahydrochloride; Emax, maximal response; WAY100635, N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl); NAN190, 1-(2-methoxyphenyl)-4-[4-(2-phthalimido)butyl]piperazine.

    • Received January 8, 2004.
    • Accepted April 2, 2004.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 310 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 310, Issue 1
1 Jul 2004
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Desensitization of 5-HT1A Receptors by 5-HT2A Receptors in Neuroendocrine Neurons in Vivo
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleNEUROPHARMACOLOGY

Desensitization of 5-HT1A Receptors by 5-HT2A Receptors in Neuroendocrine Neurons in Vivo

Yahong Zhang, Thackery S. Gray, Deborah N. D'Souza, Gonzalo A. Carrasco, Katerina J. Damjanoska, Bertalan Dudas, Francisca Garcia, Gina M. Zainelli, Nicole R. Sullivan Hanley, George Battaglia, Nancy A. Muma and Louis D. Van de Kar
Journal of Pharmacology and Experimental Therapeutics July 1, 2004, 310 (1) 59-66; DOI: https://doi.org/10.1124/jpet.103.062224

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleNEUROPHARMACOLOGY

Desensitization of 5-HT1A Receptors by 5-HT2A Receptors in Neuroendocrine Neurons in Vivo

Yahong Zhang, Thackery S. Gray, Deborah N. D'Souza, Gonzalo A. Carrasco, Katerina J. Damjanoska, Bertalan Dudas, Francisca Garcia, Gina M. Zainelli, Nicole R. Sullivan Hanley, George Battaglia, Nancy A. Muma and Louis D. Van de Kar
Journal of Pharmacology and Experimental Therapeutics July 1, 2004, 310 (1) 59-66; DOI: https://doi.org/10.1124/jpet.103.062224
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • CVN424, a novel GPR6 inverse agonist for Parkinson's disease
  • Methylone Brain Concentrations and Pharmacodynamic Effects
  • Oxysterols and Ethanol
Show more Neuropharmacology

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics